Eli Lilly will invest more than US$1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday (Oct 6), as it seeks to tap into a skilled workforce to bolster its global manufacturing expansion. The collaborations aim to increase the availability of Lilly's key drugs, including those for obesity, diabetes, Alzheimer's, cancer and autoimmune conditions, the company said. "We are making significant investments to increase